MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

March 21, 2016

New York/Geneva, March 21, 2016—Two years after two new drugs to treat tuberculosis (TB)—the first in over 50 years—were conditionally approved for use, only two percent of the 150,000 people who need them most have been able to access them, according to Doctors Without Borders’ new edition of DR-TB Drugs Under the Microscope.

August 06, 2015

In Uzbekistan’s Autonomous Republic of Karakalpakstan, Doctors Without Borders/Médecins Sans Frontières (MSF) runs a tuberculosis (TB) program in collaboration with the Ministry of Health, helping patients manage the side effects of their drug regimens and providing psychosocial support to improve treatment adherence. Here, MSF medical team leader Tetyana Pylypenko discusses MSF’s

December 17, 2013

Tuberculosis (TB) and its drug-resistant forms are a global health threat to which children are particularly vulnerable.

July 11, 2013

MSF doctor Emily Wise blogs from Karakalpakstan, Uzbekistan, where MSF is working to treat tuberculosis patients.

May 05, 2013

A mobile MSF TB surgery mission has successfully completed surgery on six DR-TB patients in Yeravan, Armenia.

April 05, 2012

In northwestern Uzbekistan, drug-resistant forms of tuberculosis (TB) are spreading while only one in 10 people with TB receives treatment. Doctors Without Borders/Médecins Sans Frontières (MSF) has treated more than 2,000 people with drug-resistant TB in Uzbekistan over the last 10 years.

Pages

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

March 21, 2016

New York/Geneva, March 21, 2016—Two years after two new drugs to treat tuberculosis (TB)—the first in over 50 years—were conditionally approved for use, only two percent of the 150,000 people who need them most have been able to access them, according to Doctors Without Borders’ new edition of DR-TB Drugs Under the Microscope.

August 06, 2015

In Uzbekistan’s Autonomous Republic of Karakalpakstan, Doctors Without Borders/Médecins Sans Frontières (MSF) runs a tuberculosis (TB) program in collaboration with the Ministry of Health, helping patients manage the side effects of their drug regimens and providing psychosocial support to improve treatment adherence. Here, MSF medical team leader Tetyana Pylypenko discusses MSF’s

December 17, 2013

Tuberculosis (TB) and its drug-resistant forms are a global health threat to which children are particularly vulnerable.

July 11, 2013

MSF doctor Emily Wise blogs from Karakalpakstan, Uzbekistan, where MSF is working to treat tuberculosis patients.

May 05, 2013

A mobile MSF TB surgery mission has successfully completed surgery on six DR-TB patients in Yeravan, Armenia.

April 05, 2012

In northwestern Uzbekistan, drug-resistant forms of tuberculosis (TB) are spreading while only one in 10 people with TB receives treatment. Doctors Without Borders/Médecins Sans Frontières (MSF) has treated more than 2,000 people with drug-resistant TB in Uzbekistan over the last 10 years.

Pages